Iovance Biotherapeutics Updates Corporate Presentation (Aug 2026)

What Happened
Iovance Biotherapeutics, Inc. announced on August 6, 2026 that it has updated its corporate presentation used for healthcare conferences, analyst briefings, current stockholders and other external audiences. The presentation the company intends to use at such events is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference.

Key Details

• Filing date: August 6, 2026 (Form 8-K Item 8.01).
• The updated slide deck is filed as Exhibit 99.1 to the 8-K.
• The presentation will be used at healthcare conferences and in communications with analysts, current stockholders and other third parties.

Why It Matters
An updated corporate presentation is the company's primary public messaging tool for investors and analysts. Reviewing Exhibit 99.1 can show any changes in corporate strategy, program status, timelines or clinical highlights that Iovance will emphasize in upcoming conferences and investor communications. Retail investors should review the attached presentation for any material updates to the company’s programs or guidance.